TT, for us long term holders we are all disappointed, but if the...

First 26 Last

Share
Profile

Follow
applesanddiamonds

610 Posts.

141

11/03/20

13:44

Post #: 43426788
Share

Originally posted by TerribleTadpole: ↑

My plan was to trade the dead cat bounces on a negative announcement, but the company scuttled that one by announcing before the open. Last time it was a shocker I was able to preserve my capital through the crash by doing that. Not this time.

Now my plan is to escape at my break-even of 10.5c and make enquiries about whether legal action is a viable option after the misleading and deceptive quarterly report. I might be back to invite expressions of interest in a class action. Otherwise I'm done with ResApp.

This is strike three for management from my perspective. They're out.

I don't think ResApp is dead by a long shot, but I see a long, slow haul to commercialisation. If the FDA want information that can be obtained without a clinical trial then I think FDA approval might come early in 2021. If there's going to be another clinical trial then they're probably looking at some time in 2022. In the meantime management will be looking to commercialise ResAppDx in jurisdictions where they have approval (Australia and Europe, primarily). There's also the sleep apnea product to develop. Those options should support a price in the teens (of cents) rather than below 10c like last time.

But does anybody believe that this management team can successfully commercialise what they have? I certainly don't. I see them as a bunch of complete numpties with questionable capabilities and questionable integrity.

Expand

TT, for us long term holders we are all disappointed, but if the decision had gone the other way and approval given you would have been with us all at the front cheerleading.
This company has huge opportunity. I for one would not support any class action.

I've bought more today and I am going to make a lot of money with RAP.

DYOR

RAP Price at posting: 8.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

ASX Market Update: ASX200 in the red but real estate faring better | 1 June 2024

ITM

iTech lifts MRE at Eyre Peninsula Graphite Project by 300%

LIN

Lindian shares jump on news of low-cost feasibility results for Kangankunde REE project

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

There are more pages in this discussion • 11 more messages in this thread...

First 26 Last

Add RAP (ASX) to my watchlist

TT, for us long term holders we are all disappointed, but if the...

Top Stories

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

ASX Market Update: ASX200 in the red but real estate faring better | 1 June 2024

iTech lifts MRE at Eyre Peninsula Graphite Project by 300%

Lindian shares jump on news of low-cost feasibility results for Kangankunde REE project

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Featured News